Cooper Companies | COO - Ebit

Aktienkurs
60.94
Täglich Wechseln
1.33 2.23%
Monatlich
-12.27%
Jährlich
-25.60%
Q2 Prognose
58.41




Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
Align Technology USD 178.05M 46.66M 2026-03
AtriCure USD 526K 1.96M 2026-03
Avanos Medical USD 8.9M 15.87M 2026-03
Bausch Health Companies USD 489M 230M 2026-03
Baxter International USD 66M 280.2M 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Boston Scientific USD 1.05B 190M 2026-03
Cooper Companies USD 212.8M 72.4M 2025-12
Dentsply International USD 32M 506M 2026-03
Dexcom USD 255.3M 67.7M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Globus Medical USD 164M 17.31M 2026-03
Haemonetics USD 67.4M 13.71M 2025-12
Insulet USD 122M 24.3M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.51B 2026-03
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 44.16M 10.04M 2026-03
Novartis USD 4.06B 413M 2025-12
ResMed USD 505.67M 8.07M 2026-03
STAAR Surgical USD 17.4M 28.34M 2026-03
Steris USD 318.7M 40.7M 2026-03
Stryker USD 1.1B 867M 2026-03
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 37.03M 686K 2026-03
Utah Medical Products USD 2.44M 2M 2025-12
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03